WSU cancer therapy shows promise in trials

By WSU News & Media Relations

By Rachel Tompa, Fred Hutch News

BlackPULLMAN, Wash. – A recent small clinical trial for patients with a rare, aggressive brain cancer has shown promise. The targeted cancer therapy enlists a modified yeast protein that is the brainchild of Washington State University biologist Margaret Black.

The early-stage human trial results were published last month in Science Translational Medicine.

Black recognized that, with a few tweaks, a natural yeast molecule could have potent anti-tumor power, according to an article about the research in this week’s Fred Hutchinson Cancer Research Center newsletter. Read the article by Rachel Tompa at http://www.fredhutch.org/en/news/center-news/2016/07/dr-barry-stoddard-glioblastoma-experimental-drug.html.

 

Next Story

The past is not that long ago

Washington State Magazine explores the complicated ties that continue to reverberate between the Pacific Northwest’s indigenous tribes and the first Jesuit priest to the region.
By Washington State Magainze,

Recent News

Aging societies more vulnerable to collapse

Societies and political structures, like the humans they serve, appear to become more fragile as they age, according to an analysis of hundreds of pre-modern societies.
By WSU News & Media Relations

Insider will return Monday, Nov. 27

WSU Insider is taking a break to join with the rest of the university community in celebrating the Thanksgiving holiday. We’ll be back the morning of Nov. 27 with fresh posts and all the latest WSU information.
By WSU News & Media Relations

Charting a clear path forward for WSU Athletics

Statement from WSU President Kirk Schulz and Director of Athletics Pat Chun about today’s ruling affirming that the future of the Pac‑12 should be determined by the members who remain in the conference rather than those who are leaving.
By Kirk Schulz, System President, Washington State University